abstract |
The present invention relates to a series of quinoline and quinoxaline derivatives comprising a fluorinated ethyl side chain, which are selective inhibitors of PI3 kinase enzymes, and are therefore of benefit in medicine, for example in the treatment of conditions. inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic. |